Skip to content

Dokter Frank Dewaele

Active
Private limited company (pre-2019)founded 2003active for 23 yearsWillebringsestraat 43, 3370 Boutersem, BelgiumKBO/BCE: BE 0859.846.503
Summary

Dokter Frank Dewaele has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €435,076 and a net result of €56,448. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 76% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
1 site
Size
≈ €220,000turnover 2025, estimated
Equity
€435,076
Profit
€56,448
Turnover estimated from the gross margin
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 31 days late2 deeds in the Belgian Official Gazette
Why 96raises riskLast filed accounts filed 31 days late; 1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 7.83, cash €198,899Equity €435,076 (84.8% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 65% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 84.8% of total assets
Liquidity 98+13
short-term debt 10.4% · cash 38.8%
Profitability 83-14
return on assets 11.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity ample (current ratio 7.83, compared with 5.57 in 2024, above the usual 1.5; short-term debt: 10.4% and cash: 38.8% of total assets), and 15.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 87% on liquidity, 31% on profitability and 58% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 7.83, cash €198,899
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 1 of the last 3 late
NBB · filings
lowers risk · Equity €435,076 (84.8% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
28 days late
2023
on the day
2022
30 days late
2021
29 days late
2020
61 days late
2019
63 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 35 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €110,935 ▲39.5%

Key points

  • Caution: Result fell in 2025from €110,935 to €56,448 ▼ 49.1% View
  • Positive: 8 profitable years in a rowprofit 2025: €56,448 8 years View
  • Total assets 20256 financial years filed €512,822 View

By topic

Financials

Financial year
2025
Total assets
€512,822
Profit
€56,448
Solvency
84.8%
Total assets▲ 5.8%
Net result
20182025
Go to Financials

Timeline

Events
24
Since
2005
Next accounts
by 31-07-2027
  1. 31-07-2024Annual accounts filed
  2. 30-08-2023Annual accounts filed
  3. 29-08-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
30-07-2003
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dokter Frank Dewaele

What is the company number of Dokter Frank Dewaele?
0859.846.503. In Belgium the VAT number is the company number with BE in front: BE 0859.846.503.
Where is Dokter Frank Dewaele based?
The registered office is at Willebringsestraat 43, 3370 Boutersem.Company details
What does Dokter Frank Dewaele do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of Dokter Frank Dewaele?
Private limited company (pre-2019) (BVBA).
When was Dokter Frank Dewaele founded?
On 30-07-2003.
Is Dokter Frank Dewaele still active?
Yes, Dokter Frank Dewaele is an active enterprise in the KBO register.
What is the turnover of Dokter Frank Dewaele?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dokter Frank Dewaele profitable?
In financial year 2025, Dokter Frank Dewaele made a profit of €56,448.
Where can I find the annual accounts of Dokter Frank Dewaele?
Dokter Frank Dewaele filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokter Frank Dewaele due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Dokter Frank Dewaele

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.